16th Jul 2014 08:46
LONDON (Alliance News) - IT services company Instem PLC said Wednesday that it has won two new contracts in the Asia-Pacific region.
Instem said the first is a five-year contract with Chinese research organisation, the National Shanghai Center for Drug Safety Evaluation and Research. The NCDSER has purchased Instem's integrated Provantis pre-clinical software suite to automate laboratory processes at their R&D facility in Shanghai, China.
The contract was awarded following a competitive evaluation and is of significant importance to Instem as it strengthens its foothold in the Asia-Pacific region, said the company. The Provantis suite will be delivered using the software-as-a-service delivery model from Instem's Shanghai-based data center, adding another large laboratory to Instem's established hosting data centre client roster.
The IT services provider to the early development healthcare market has also signed a contract with an unnamed corporation, which has purchased Instem's submit solution suite to support Clinical Data Interchange Standards Consortium's Standard for Exchange of Nonclinical Data.
SEND defines the organisation, structure, and format of standard non-clinical tabulation datasets for interchange between organisations such as sponsors and CROs and for submission to the US Food and Drug Administration.
No financial terms of the deals were disclosed.
Shares in Instem were Wednesday trading marginally lower, down 1.11% at 178.00 pence per share.
By Alice Attwood; [email protected]; @AliceAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
INS.L